Evidence map›Paper›PMID 34639050›Full record

ArticleInternational journal of molecular sciences2021

Supercritical Carbon Dioxide Treatment of Porous Silicon Increases Biocompatibility with Cardiomyocytes.

David Jui-Yang Feng, Hung-Yin Lin, James L Thomas, Hsing-Yu Wang, Chien-Yu Lin, Chen-Yuan Chen, Kai-Hsi Liu, Mei-Hwa Lee

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

David Jui-Yang FengDepartment of Electrical Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.ORCID 0000-0001-5841-2225
Hung-Yin LinDepartment of Chemical and Materials Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.
James L ThomasDepartment of Physics and Astronomy, University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0002-2420-7992
Hsing-Yu WangDepartment of Electrical Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.
Chien-Yu LinDepartment of Chemical and Materials Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.
Chen-Yuan ChenDepartment of Chemical and Materials Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.
Kai-Hsi LiuDepartment of Electrical Engineering, National University of Kaohsiung, Kaohsiung 81148, Taiwan.
Mei-Hwa LeeDepartment of Materials Science and Engineering, I-Shou University, Kaohsiung 84001, Taiwan.
National University of Kaohsiung · TWI-Shou University · TWUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porous silicon is of current interest for cardiac tissue engineering applications. While porous silicon is considered to be a biocompatible material, it is important to assess whether post-etching surface treatments can further improve biocompatibility and perhaps modify cellular behavior in desirable ways. In this work, porous silicon was formed by electrochemically etching with hydrofluoric acid, and was then treated with oxygen plasma or supercritical carbon dioxide (scCO

Indexed as

Myocytes, CardiacBiocompatible MaterialsBioengineeringCarbon DioxideCell SurvivalPorositySiliconSpectrum AnalysisSurface PropertiesBiocompatible MaterialsCarbon DioxideSiliconangiogenesisbiocompatibilitycardiomyocyteporous siliconsurface treatment

Identifiers

PMID34639050
PMCPMC8509595
OpenAlexW3202623731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.